Exemestane vs Ketoconazole
FDA Approved vs FDA Approved
monitor Mechanism-based · 60% Both Exemestane and Ketoconazole carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects.
Molecular Data
Exemestane Ketoconazole
Weight 296.40 Da 531.43 Da
Half-life ~24 hours Topical application stays local with minimal systemic absorption
Type Steroidal aromatase inhibitor (irreversible, suicide inhibitor) Synthetic imidazole antifungal
Key Benefits
Exemestane
01 Irreversible aromatase inactivation eliminates estrogen rebound upon discontinuation
02 Steroidal structure with mild androgenic activity may offset some low-estrogen side effects
03 Potent estrogen suppression (85-95% reduction in estradiol at full dose)
04 Compatible with tamoxifen (unlike anastrozole, no pharmacokinetic interference)
05 Prevents gynecomastia during testosterone or aromatizable steroid cycles
06 Reduces estrogen-driven water retention, bloating, and blood pressure elevation
07 Oral dosing with once-daily or less frequent administration for cycle support
Ketoconazole
01 Disrupts DHT binding at the follicle level with topical application
02 Reduces Malassezia colonization and scalp inflammation associated with hair loss
03 Negligible systemic absorption when used as a shampoo
04 FDA-approved and widely available over the counter (1%) or by prescription (2%)
05 Part of the established "big 3" hair loss protocol with finasteride and minoxidil
06 Treats concurrent seborrheic dermatitis and dandruff while addressing hair loss
07 Simple to incorporate into existing shower routines
Side Effects
Exemestane
Joint pain and stiffness (generally less severe than with anastrozole due to mild androgenic activity)
Fatigue and general malaise
Hot flashes or flushing
Mood changes (irritability, flat affect, low mood)
Headache
Increased sweating
Ketoconazole
Scalp dryness with regular use
Mild scalp irritation or itching at application site
Changes in hair texture (temporary dryness or coarseness)
Contraindications
Known hypersensitivity to exemestane or any excipients
Premenopausal women (not indicated and potentially harmful to reproductive function)
Pregnancy or breastfeeding (teratogenic risk)
Severe hepatic impairment
Pre-existing severe osteoporosis or high fracture risk
Concurrent use with other aromatase inhibitors (anastrozole, letrozole)
Known hypersensitivity to ketoconazole or any imidazole antifungal
Open wounds or severely broken skin on the scalp
Oral ketoconazole is contraindicated in liver disease (not applicable to shampoo use)
Research Evidence
Exemestane Ketoconazole
Status FDA Approved FDA Approved
References 5 studies 4 studies
FDA Approved Yes Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.